Biondo Investment Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-62,211
| Closed | -$3.99M | – | 93 |
|
|
2018
Q4 | $3.99M | Sell |
62,211
-46,440
| -43% | -$2.98M | 1.2% | 27 |
|
|
2018
Q3 | $9.72M | Buy |
108,651
+120
| +0.1% | +$10.7K | 2.31% | 12 |
|
|
2018
Q2 | $8.62M | Sell |
108,531
-3,745
| -3% | -$297K | 2.17% | 12 |
|
|
2018
Q1 | $10M | Sell |
112,276
-18,426
| -14% | -$1.64M | 2.61% | 9 |
|
|
2017
Q4 | $13.6M | Sell |
130,702
-5,225
| -4% | -$545K | 3.45% | 6 |
|
|
2017
Q3 | $19.8M | Buy |
135,927
+1,320
| +1% | +$192K | 5.45% | 4 |
|
|
2017
Q2 | $17.5M | Sell |
134,607
-7,215
| -5% | -$937K | 5.06% | 4 |
|
|
2017
Q1 | $14M | Sell |
141,822
-380
| -0.3% | -$37.5K | 5% | 3 |
|
|
2016
Q4 | $16.5M | Sell |
142,202
-840
| -0.6% | -$97.2K | 5.44% | 3 |
|
|
2016
Q3 | $15M | Buy |
143,042
+1,105
| +0.8% | +$116K | 5.06% | 4 |
|
|
2016
Q2 | $14M | Sell |
141,937
-2,297
| -2% | -$227K | 5% | 3 |
|
|
2016
Q1 | $14.4M | Sell |
144,234
-55,735
| -28% | -$5.58M | 5.47% | 3 |
|
|
2015
Q4 | $23.9M | Sell |
199,969
-7,795
| -4% | -$934K | 7.94% | 1 |
|
|
2015
Q3 | $22.5M | Sell |
207,764
-3,124
| -1% | -$338K | 7.47% | 1 |
|
|
2015
Q2 | $24.4M | Sell |
210,888
-1,059
| -0.5% | -$123K | 7.33% | 1 |
|
|
2015
Q1 | $24.4M | Sell |
211,947
-3,155
| -1% | -$364K | 7.25% | 2 |
|
|
2014
Q4 | $24.1M | Buy |
215,102
+3,615
| +2% | +$404K | 7.24% | 2 |
|
|
2014
Q3 | $20M | Sell |
211,487
-4,180
| -2% | -$396K | 6.16% | 2 |
|
|
2014
Q2 | $18.5M | Sell |
215,667
-1,381
| -0.6% | -$119K | 5.84% | 2 |
|
|
2014
Q1 | $15.2M | Sell |
217,048
-6,928
| -3% | -$484K | 5.02% | 5 |
|
|
2013
Q4 | $18.9M | Sell |
223,976
-16,214
| -7% | -$1.37M | 6.46% | 2 |
|
|
2013
Q3 | $18.5M | Sell |
240,190
-7,580
| -3% | -$584K | 7.02% | 2 |
|
|
2013
Q2 | $14.5M | Buy |
+247,770
| New | +$14.5M | 6.28% | 5 |
|